Abstract
Objective: to evaluate the clinical and hemodynamic effects of CPAP-therapy in the treatment of alveolar cardiogenic pulmonary edema (CPE) in patients with acute myocardial infarction (AMI). Subjects and methods. The open-labeled prospective study included 22 patients (19 males; mean age, 59.2±5.8 years) with CPE that had complicated the course of AMI. Despite the drug and oxygen therapies of CPE for 30 minutes, progressive respiratory and left ventricular failures were an indication for the initiation of CPAP-therapy (7.3±1.2 cm H2O) that was performed, by employing REM-Star apparatuses (Respironics, USA) and Ultra Mirage facial masks (ResMed, Australia). Oxygen, 2 l/min (FiO2 = 40%), was delivered through the mask circuit. Central hemodynamic parameters were measured before and 60 and 180 minutes after the initiation of CPAP-therapy, by using a Swan-Ganz thermodilution cathether (HANDS OFF, model AH-05000-H, ARROW, USA). Arterial and mixed venous blood gas composition was rapidly determined on an automatic gas analyzer (Rapidlab 348, Bayer, USA). Results. Cyanosis and acrocyanosis disappeared and the number of congestive moist rales reduced in the lung in 19 (86.4%) patients during 30-min CPAP-therapy. The patients’ oxygen status changed: the value of PaO2 significantly increased (82.5±2.5 versus 57.4±4.2 mm Hg at the baseline;p<0.05); SaO2 reached the normal values 60 minutes following CPAP-therapy. There was an increase in the cardiac index (3.1±0.2 versus 2.3±0.1 l/min/m2 at the baseline; p<0.05), a decrease in pulmonary wedge pressure (14.4±21 versus 23.6±2.1 mm Hg at the baseline; p<0.05), and synchronism of right and left cardiac performance. Conclusion. CPAP-therapy optimizes treatment of patients with CPE-complicated AMI, results in the normalization of the arterial blood gas composition, significantly diminishes hydrostatic pulmonary capillary pressure, and promotes the synchronism of the right and left hearts.
Highlights
Цель: оценить клинические и гемодинамические эффекты СРАР терапии в лечении альвеолярного кардиогенного оте ка легких (КОЛ) у пациентов с острым инфарктом миокарда (ОИМ)
The open labeled prospec tive study included 22 patients (19 males; mean age, 59.2±5.8 years) with cardiogenic pul monary edema (CPE) that had complicated the course of acute myocardial infarction (AMI)
Despite the drug and oxygen therapies of CPE for 30 minutes, progressive respiratory and left ventricular failures were an indication for the initiation of CPAP therapy (7.3±1.2 cm H2O) that was performed, by employing REM Star apparatuses (Respironics, USA) and Ultra Mirage facial masks (ResMed, Australia)
Summary
Clinical and Hemodynamic Effects of CPAP Therapy in Patients with Cardiogenic Pulmonary Edema. Цель: оценить клинические и гемодинамические эффекты СРАР терапии в лечении альвеолярного кардиогенного оте ка легких (КОЛ) у пациентов с острым инфарктом миокарда (ОИМ). CPAP терапия оптимизирует лечение пациентов с ОИМ, осложненным КОЛ, приводит к нормализации газового состава артериальной крови, достоверно снижает гид ростатическое легочное капиллярное давление, способствует синхронизации правых и левых отделов сердца. Objective: to evaluate the clinical and hemodynamic effects of CPAP therapy in the treatment of alveolar cardiogenic pul monary edema (CPE) in patients with acute myocardial infarction (AMI). CPAP therapy optimizes treatment of patients with CPE complicated AMI, results in the normalization of the arterial blood gas composition, significantly diminishes hydrostatic pulmonary capillary pressure, and promotes the synchronism of the right and left hearts. Целью проводимого исследования явилась оценка клинических и гемодинамических эффек тов СРАР терапии (Continuous Positive Airway Pressure — CPAP) в лечении альвеолярного кар диогенного отека легких у пациентов с острым ин фарктом миокарда
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.